Tamás Horváth

Dr. Tamás Horváth


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CBCsilla Balla-Bartos
Csilla Balla-Bartos
PSPiroska Szabó-Révész
Piroska Szabó-Révész
THTamás Horváth
Tamás Horváth
PVPatricia Varga
Patricia Varga
Rita AmbrusRita Ambrus
Rita Ambrus
Nowadays, the intranasal route has become a reliable alternative route for drug administration to the systemic circulation or central nervous system. However, there are no official in vitro diffusion and dissolution tests especially for the investigation of nasal formulations. Our main goal was to study and compare a well-known and a lesser-known in vitro permeability investigation method, in order to ascertain which was suitable for the determination of drug permeability through the nasal mucosa from different formulations. The vertical diffusion cell (Franz cell) was compared with the horizontal diffusion model (Side-Bi-Side). Raw and nanonized meloxicam containing nasal dosage forms (spray, gel and powder) were tested and compared. It was found that the Side-Bi-Side cell was suitable for the investigation of spray and powder forms. In contrast, the gel was not measurable on the Side-Bi-Side cell; due to its high viscosity, a uniform distribution of the active substance could not be ensured in the donor phase. The Franz cell, designed for the analysis of semi-solid formulations, was desirable for the investigation of nasal gels. It can be concluded that the application of a horizontal cell is recommended for liquid and solid nasal preparations, while the vertical one should be used for semi-solid formulations.

1 December 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
THTamás Horváth
Tamás Horváth
RARita Ambrus
Rita Ambrus
GVGergely Völgyi
Gergely Völgyi
MBMária Budai-Szűcs
Mária Budai-Szűcs
ÁMÁrpád Márki
Árpád Márki
PSPiroska Szabó-Révész
Piroska Szabó-Révész

18 May 2016 in Molecules
Verified
Journal Article
Open access
PDF file
THTamás Horváth
Tamás Horváth
CBCsilla Bartos
Csilla Bartos
ABAlexandra Bocsik
Alexandra Bocsik
LKLorand Kiss
Lorand Kiss
Szilvia VeszelkaSzilvia Veszelka
Szilvia Veszelka
Rita AmbrusRita Ambrus
Rita Ambrus
The nasal route receives a great deal of attention as a non-invasive method for the systemic administration of drugs. For nasal delivery, specific formulations containing excipients are used. Because of the sensitive respiratory mucosa, not only the active ingredients, but also additives need to be tested in appropriate models for toxicity. The aim of the study was to measure the cytotoxicity of six pharmaceutical excipients, which could help to reach larger residence time, better permeability, and increased solubility dissolution rate. The following excipients were investigated on RPMI 2650 human nasal septum tumor epithelial cells: β-d-mannitol, sodium hyaluronate, α and β-cyclodextrin, polyvinyl alcohol and methylcellulose. 3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye conversion assay and real-time impedance analysis were used to investigate cytotoxicity. No excipient showed toxicity at 0.3% (w/v) concentration or below while 1% concentration a significantly reduced metabolic activity was measured by MTT assay for methylcellulose and cyclodextrins. Using impedance measurements, only β-cyclodextrin (1%) was toxic to cells. Mannitol at 1% concentration had a barrier opening effect on epithelial cells, but caused no cellular damage. Based on the results, all additives at 0.3%, sodium hyaluronate and polyvinyl alcohol at 1% concentrations can be safely used for nasal formulations.